FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088894564> ?p ?o ?g. }

• W2088894564 endingPage "440" @default.
• W2088894564 startingPage "435" @default.
• W2088894564 abstract "Patients given allogeneic hematopoietic stem cell transplants (HSCT) may develop secondary malignant neoplasms (SMN). Several variables have been identified but there are no data about the incidence of this complication in individuals given HSCT using reduced-intensity conditioning (RIC) methods.Define the incidence of SMN in patients given HSCT using a RIC preparative regimen conducted on an outpatient basis.Patients given HSCT in two institutions between October 1998 and 2012 were analyzed. To appraise the SMN appearance, those patients dead were also regarded as censored at that moment, as well as those lost to follow up and those alive at the closing of the study. 95% Confidence intervals (CI) for the survival or failure estimate were calculated with the Greenwood's method.A total of 416 allografted patients with a Karnofsky performance index of 100% were included in the study. All patients received peripheral blood stem cells allografts. The conditioning regimen was delivered as an outpatient procedure in all individuals. No patient was given radiotherapy nor antithymocyte globulin during the conditioning. Three hundred and sixty five patients (88%) were never admitted to the hospital, whereas 12% were admitted because of grade III-IV acute graft versus host disease (aGVHD), fever, or mucositis. Median survival time was 15.7 months. Survival at 6 months (95% CI): 66.4% (61.5-70.8%), at 12 months: 53.3% (48.1-58.1%), at 60 months: 30.6% (30.5-41.5%). Eight patients with a SMN were identified in the group of 416 allografted patients, SMN rates (95% CI) were: one year post graft: 1.9% (0.7-4.9%), 5 years: 3.8% (1.6-9.2%), 10 years: 6.8% (2.6-17.7%) and 13 years post-graft: 20.2% (5.5-59.2%), the cumulative probability of SMN being 6.8 at 10 years. Since the number of expected cases in the general population is 0.62, the ratio of observed to expected cases is 12.9 (P < 0.001). This figure means that the risk of developing a malignant neoplasm in allografted individuals using our method is 12.9 times higher than that in the general population. There were three non-Hodgkin's lymphomas, two M2 acute myelogenous leukemias, one hairy cell leukemia, one tongue epidermoid carcinoma, and one breast carcinoma.We have found a low incidence of SMN in this group of Mexican patients allografted with the Mexican RIC method. Possible explanations for this difference are discussed, focusing on the RIC preparative regimen." @default.
• W2088894564 created "2016-06-24" @default.
• W2088894564 creator A5000360404 @default.
• W2088894564 creator A5019552459 @default.
• W2088894564 creator A5022592090 @default.
• W2088894564 creator A5027191240 @default.
• W2088894564 creator A5035363124 @default.
• W2088894564 creator A5083338848 @default.
• W2088894564 creator A5091251150 @default.
• W2088894564 date "2014-02-20" @default.
• W2088894564 modified "2023-10-17" @default.
• W2088894564 title "Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction" @default.
• W2088894564 cites W131854666 @default.
• W2088894564 cites W1497143314 @default.
• W2088894564 cites W1531313823 @default.
• W2088894564 cites W1534044897 @default.
• W2088894564 cites W1907319801 @default.
• W2088894564 cites W1933695467 @default.
• W2088894564 cites W1970994186 @default.
• W2088894564 cites W1972334401 @default.
• W2088894564 cites W1987330130 @default.
• W2088894564 cites W1992377102 @default.
• W2088894564 cites W1992970202 @default.
• W2088894564 cites W2024853215 @default.
• W2088894564 cites W2036855207 @default.
• W2088894564 cites W2069362461 @default.
• W2088894564 cites W2069644796 @default.
• W2088894564 cites W2071749891 @default.
• W2088894564 cites W2074695959 @default.
• W2088894564 cites W2093382617 @default.
• W2088894564 cites W2103006033 @default.
• W2088894564 cites W2117207051 @default.
• W2088894564 cites W2159181839 @default.
• W2088894564 cites W2170212894 @default.
• W2088894564 cites W2334624221 @default.
• W2088894564 cites W2342320434 @default.
• W2088894564 cites W3117239408 @default.
• W2088894564 doi "https://doi.org/10.1179/1607845414y.0000000154" @default.
• W2088894564 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24552480" @default.
• W2088894564 hasPublicationYear "2014" @default.
• W2088894564 type Work @default.
• W2088894564 sameAs 2088894564 @default.
• W2088894564 citedByCount "6" @default.
• W2088894564 countsByYear W20888945642015 @default.
• W2088894564 countsByYear W20888945642016 @default.
• W2088894564 countsByYear W20888945642017 @default.
• W2088894564 countsByYear W20888945642022 @default.
• W2088894564 countsByYear W20888945642023 @default.
• W2088894564 crossrefType "journal-article" @default.
• W2088894564 hasAuthorship W2088894564A5000360404 @default.
• W2088894564 hasAuthorship W2088894564A5019552459 @default.
• W2088894564 hasAuthorship W2088894564A5022592090 @default.
• W2088894564 hasAuthorship W2088894564A5027191240 @default.
• W2088894564 hasAuthorship W2088894564A5035363124 @default.
• W2088894564 hasAuthorship W2088894564A5083338848 @default.
• W2088894564 hasAuthorship W2088894564A5091251150 @default.
• W2088894564 hasConcept C120665830 @default.
• W2088894564 hasConcept C121332964 @default.
• W2088894564 hasConcept C126322002 @default.
• W2088894564 hasConcept C141071460 @default.
• W2088894564 hasConcept C2777408962 @default.
• W2088894564 hasConcept C2778496288 @default.
• W2088894564 hasConcept C2781413609 @default.
• W2088894564 hasConcept C2911091166 @default.
• W2088894564 hasConcept C2993801483 @default.
• W2088894564 hasConcept C509974204 @default.
• W2088894564 hasConcept C61511704 @default.
• W2088894564 hasConcept C71924100 @default.
• W2088894564 hasConceptScore W2088894564C120665830 @default.
• W2088894564 hasConceptScore W2088894564C121332964 @default.
• W2088894564 hasConceptScore W2088894564C126322002 @default.
• W2088894564 hasConceptScore W2088894564C141071460 @default.
• W2088894564 hasConceptScore W2088894564C2777408962 @default.
• W2088894564 hasConceptScore W2088894564C2778496288 @default.
• W2088894564 hasConceptScore W2088894564C2781413609 @default.
• W2088894564 hasConceptScore W2088894564C2911091166 @default.
• W2088894564 hasConceptScore W2088894564C2993801483 @default.
• W2088894564 hasConceptScore W2088894564C509974204 @default.
• W2088894564 hasConceptScore W2088894564C61511704 @default.
• W2088894564 hasConceptScore W2088894564C71924100 @default.
• W2088894564 hasIssue "8" @default.
• W2088894564 hasLocation W20888945641 @default.
• W2088894564 hasLocation W20888945642 @default.
• W2088894564 hasOpenAccess W2088894564 @default.
• W2088894564 hasPrimaryLocation W20888945641 @default.
• W2088894564 hasRelatedWork W1994541287 @default.
• W2088894564 hasRelatedWork W2040606303 @default.
• W2088894564 hasRelatedWork W2292761556 @default.
• W2088894564 hasRelatedWork W2307041520 @default.
• W2088894564 hasRelatedWork W2357360784 @default.
• W2088894564 hasRelatedWork W2357833128 @default.
• W2088894564 hasRelatedWork W3030594888 @default.
• W2088894564 hasRelatedWork W3031485523 @default.
• W2088894564 hasRelatedWork W3031785916 @default.
• W2088894564 hasRelatedWork W3032640740 @default.
• W2088894564 hasVolume "19" @default.
• W2088894564 isParatext "false" @default.
• W2088894564 isRetracted "false" @default.

• next